Zelira Therapeutics Ltd (ASX:ZLD) is a leading global therapeutic medical cannabis company with access to the world’s largest and fastest growing cannabis markets.
Zelira is undertaking product development programs targeting specific conditions and human clinical trial programs focused on insomnia, autism and opioid reduction in patients with chronic non-cancer pain.
Small caps
Zelira Therapeutics sees 'multiple shots on goal' with a number of revenue streams
Director Interviews
Zelira Therapeutics forms exclusive licensing deal to distribute its HOPE products in Washington DC
